Ckd Bio (063160) - Total Liabilities

Latest as of March 2026: ₩173.38 Billion KRW ≈ $117.50 Million USD

Based on the latest financial reports, Ckd Bio (063160) has total liabilities worth ₩173.38 Billion KRW (≈ $117.50 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Ckd Bio - Total Liabilities Trend (2008–2025)

This chart illustrates how Ckd Bio's total liabilities have evolved over time, based on quarterly financial data. See 063160 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Ckd Bio Competitors by Total Liabilities

The table below lists competitors of Ckd Bio ranked by their total liabilities.

Company	Country	Total Liabilities
Lokesh Machines Limited NSE:LOKESHMACH	India	Rs2.33 Billion
Talaad Thai Leasehold Property Fund BK:TTLPF	Thailand	฿42.32 Million
Makmur Berkah Amanda Pt JK:AMAN	Indonesia	Rp633.93 Billion
Quartiers Properties AB (publ) ST:QUART-PREF	Sweden	Skr218.07 Million
Inta Bina Group Bhd KLSE:0192	Malaysia	RM431.27 Million
N. B. I. Industrial Finance Company Limited NSE:NBIFIN	India	Rs874.88 Million
IMCO Industries Ltd TA:IMCO	Israel	ILA197.86 Million
Permianville Royalty Trust NYSE:PVL	USA	$0.00

Liability Composition Analysis (2008–2025)

This chart breaks down Ckd Bio's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Ckd Bio (063160) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.10	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.39	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.58	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Ckd Bio's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Ckd Bio (2008–2025)

The table below shows the annual total liabilities of Ckd Bio from 2008 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩172.83 Billion ≈ $117.13 Million	+12.61%
2024-12-31	₩153.48 Billion ≈ $104.01 Million	-10.12%
2023-12-31	₩170.76 Billion ≈ $115.72 Million	+3.62%
2022-12-31	₩164.79 Billion ≈ $111.68 Million	+20.24%
2021-12-31	₩137.05 Billion ≈ $92.88 Million	+19.47%
2020-12-31	₩114.71 Billion ≈ $77.74 Million	+53.19%
2019-12-31	₩74.88 Billion ≈ $50.75 Million	+103.17%
2018-12-31	₩36.86 Billion ≈ $24.98 Million	-1.55%
2017-12-31	₩37.44 Billion ≈ $25.37 Million	-18.17%
2016-12-31	₩45.75 Billion ≈ $31.00 Million	+5.73%
2015-12-31	₩43.27 Billion ≈ $29.32 Million	+0.10%
2014-12-31	₩43.22 Billion ≈ $29.29 Million	-16.27%
2013-12-31	₩51.62 Billion ≈ $34.99 Million	-15.75%
2012-12-31	₩61.28 Billion ≈ $41.53 Million	-22.72%
2011-12-31	₩79.29 Billion ≈ $53.73 Million	+88.21%
2010-12-31	₩42.13 Billion ≈ $28.55 Million	-10.72%
2009-12-31	₩47.18 Billion ≈ $31.98 Million	+3.25%
2008-12-31	₩45.70 Billion ≈ $30.97 Million	--

About Ckd Bio

KO:063160 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$59.45 Million

₩87.72 Billion KRW

Market Cap Rank

#21290 Global

#1227 in Korea

Share Price

₩15990.00

Change (1 day)

-1.11%

52-Week Range

₩15200.00 - ₩24500.00

All Time High

₩101057.67